Tower Research Capital LLC (Trc) Centessa Pharmaceuticals PLC Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,289 shares of CNTA stock, worth $41,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,289
Previous 1,298
76.35%
Holding current value
$41,636
Previous $11,000
227.27%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$363 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$181 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$176 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$114 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$108 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.72B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...